Madera, Baby Girl Ii -.
HRN: 22-65-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2023
CEFTAZIDIME 1GM (VIAL)
03/28/2023
04/03/2023
IV
54mg
Q12
Prematurity, Shift Of Antibiotics
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes